MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit.

J. Sampson, A. S. Achrol, M. K. Aghi, K. Bankiewicz, M. Bexon, S. Brem, A. Brenner, S. Chowdhary, M. Coello, B. M. Ellingson, J. R. Floyd, S. Han, S. Kesari, F. Merchant, N. Merchant, D. Randazzo, M. Vogelbaum, F. Vrionis, M. Zabek, N. Butowski

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S6
JournalEuropean Journal of Cancer
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this